News
Visible signs of psoriatic arthritis appear months and even years before a person develops the full-blown inflammatory joint ...
Discover 5 insights about psoriatic arthritis from rheumatology experts, including pain management strategies, treatment ...
A rheumatologist discusses how her understanding of chronic pain in PsA has evolved—and how it affects her approach to ...
Discover the early warning signs of psoriatic arthritis that could prevent permanent joint damage, plus expert advice on treatment options and daily management.
The following is a summary of “Association Between Patient Perception of Disease Status and Different Components of the ...
This is a developing news story. Please check back soon for updates. Tremfya reduced signs and symptoms of psoriatic ...
11d
Health on MSNWhat Does Psoriatic Arthritis Feel Like?Psoriatic arthritis is a combination of psoriasis and arthritis symptoms. You may have skin and nail changes, joint pain and ...
11d
GlobalData on MSNJ&J’s psoriatic arthritis therapy trial meets endpointsUS-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its ...
9d
Amazon S3 on MSNTreatment with LeflunomideDr. John Wade, MD, FRCPC, Rheumatologist, talks about the treatment Leflunomide for rheumatoid arthritis and psoriatic ...
Main findings - Early symptoms of psoriatic arthritis (PsA) often persist for some time before the condition is diagnosed and treated. - As a result of delays in diagnosing and treating psoriatic ...
Sotyktu significantly outperformed placebo for the treatment of psoriatic arthritis in a phase 3 trial, meeting key endpoints ...
Long-term extension data show Tremfya (guselkumab) significantly reduced symptoms and inhibited structural joint damage progression in patients with active psoriatic arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results